TALPHERA, INC. — Director's Dealing 2013

Sep 13, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACELRX PHARMACEUTICALS INC (ACRX)
CIK: 0001427925
Period of Report: 2013-09-12

Reporting Person: WAN MARK A (Director, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-09-12	Stock Option (right to buy)	$10.55	A	15000	Acquired	2023-09-12	Common Stock (15000)	Direct

Footnotes

F1: The shares subject to the option will vest monthly over two years, with the first options vested and exercisable on October 12, 2013. 100% accelerated vesting to occur immediately prior to a change of control.